124 related articles for article (PubMed ID: 15107631)
1. Safety and efficacy evaluations for vaginal and rectal use of BufferGel in the macaque model.
Patton DL; Sweeney YC; Cummings PK; Meyn L; Rabe LK; Hillier SL
Sex Transm Dis; 2004 May; 31(5):290-6. PubMed ID: 15107631
[TBL] [Abstract][Full Text] [Related]
2. Vaginal and rectal topical microbicide development: safety and efficacy of 1.0% Savvy (C31G) in the pigtailed macaque.
Patton DL; Sweeney YT; Balkus JE; Hillier SL
Sex Transm Dis; 2006 Nov; 33(11):691-5. PubMed ID: 16641825
[TBL] [Abstract][Full Text] [Related]
3. Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model.
Patton DL; Cosgrove Sweeney YT; McCarthy TD; Hillier SL
Antimicrob Agents Chemother; 2006 May; 50(5):1696-700. PubMed ID: 16641437
[TBL] [Abstract][Full Text] [Related]
4. A summary of preclinical topical microbicide rectal safety and efficacy evaluations in a pigtailed macaque model.
Patton DL; Sweeney YT; Paul KJ
Sex Transm Dis; 2009 Jun; 36(6):350-6. PubMed ID: 19556929
[TBL] [Abstract][Full Text] [Related]
5. A summary of preclinical topical microbicide vaginal safety and chlamydial efficacy evaluations in a pigtailed macaque model.
Patton DL; Cosgrove Sweeney YT; Paul KJ
Sex Transm Dis; 2008 Oct; 35(10):889-97. PubMed ID: 18607310
[TBL] [Abstract][Full Text] [Related]
6. Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models.
Zeitlin L; Hoen TE; Achilles SL; Hegarty TA; Jerse AE; Kreider JW; Olmsted SS; Whaley KJ; Cone RA; Moench TR
Sex Transm Dis; 2001 Jul; 28(7):417-23. PubMed ID: 11460027
[TBL] [Abstract][Full Text] [Related]
7. The pig-tailed macaque rectal model: microflora and chlamydial infection.
Patton DL; Cosgrove-Sweeney YT; Rabe LK; Hillier SL
Sex Transm Dis; 2001 Jul; 28(7):363-6. PubMed ID: 11460018
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States.
Mayer KH; Peipert J; Fleming T; Fullem A; Moench T; Cu-Uvin S; Bentley M; Chesney M; Rosenberg Z
Clin Infect Dis; 2001 Feb; 32(3):476-82. PubMed ID: 11170957
[TBL] [Abstract][Full Text] [Related]
9. Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites.
van De Wijgert J; Fullem A; Kelly C; Mehendale S; Rugpao S; Kumwenda N; Chirenje Z; Joshi S; Taha T; Padian N; Bollinger R; Nelson K
J Acquir Immune Defic Syndr; 2001 Jan; 26(1):21-7. PubMed ID: 11176265
[TBL] [Abstract][Full Text] [Related]
10. Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis.
Achilles SL; Shete PB; Whaley KJ; Moench TR; Cone RA
Sex Transm Dis; 2002 Nov; 29(11):655-64. PubMed ID: 12438901
[TBL] [Abstract][Full Text] [Related]
11. Microflora changes with the use of a vaginal microbicide.
Clarke JG; Peipert JF; Hillier SL; Heber W; Boardman L; Moench TR; Mayer K
Sex Transm Dis; 2002 May; 29(5):288-93. PubMed ID: 11984446
[TBL] [Abstract][Full Text] [Related]
12. Effects of nonoxynol-9 on vaginal microflora and chlamydial infection in a monkey model.
Patton DL; Kidder GG; Sweeney YC; Rabe LK; Clark AM; Hillier SL
Sex Transm Dis; 1996; 23(6):461-4. PubMed ID: 8946629
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of treatment of bacterial vaginosis with a buffering vaginal microbicide.
Harwell JI; Moench T; Mayer KH; Chapman S; Rodriguez I; Cu-Uvin S
J Womens Health (Larchmt); 2003 Apr; 12(3):255-9. PubMed ID: 12804356
[TBL] [Abstract][Full Text] [Related]
14. 0.25% chlorhexidine gluconate gel. A protective topical microbicide.
Patton DL; Sweeney YT; McKay TL; DeMers SM; Clark AM; Rabe LK; Hillier SL
Sex Transm Dis; 1998 Sep; 25(8):421-4. PubMed ID: 9773435
[TBL] [Abstract][Full Text] [Related]
15. Clinical development of microbicides for the prevention of HIV infection.
D'Cruz OJ; Uckun FM
Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
[TBL] [Abstract][Full Text] [Related]
16. Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina).
Patton DL; Kidder GG; Sweeney YC; Rabe LK; Hillier SL
Am J Obstet Gynecol; 1999 May; 180(5):1080-7. PubMed ID: 10329859
[TBL] [Abstract][Full Text] [Related]
17. Safety and acceptability of penile application of 2 candidate topical microbicides: BufferGel and PRO 2000 Gel: 3 randomized trials in healthy low-risk men and HIV-positive men.
Tabet SR; Callahan MM; Mauck CK; Gai F; Coletti AS; Profy AT; Moench TR; Soto-Torres LE; Poindexter III AN; Frezieres RG; Walsh TL; Kelly CW; Richardson BA; Van Damme L; Celum CL
J Acquir Immune Defic Syndr; 2003 Aug; 33(4):476-83. PubMed ID: 12869836
[TBL] [Abstract][Full Text] [Related]
18. HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women.
Guffey MB; Richardson B; Husnik M; Makanani B; Chilongozi D; Yu E; Ramjee G; Mgodi N; Gomez K; Hillier SL; Karim SA;
Sex Transm Infect; 2014 Aug; 90(5):363-9. PubMed ID: 24898857
[TBL] [Abstract][Full Text] [Related]
19. A Phase I study of the functional performance, safety and acceptability of the BufferGel Duet.
Ballagh SA; Brache V; Mauck C; Callahan MM; Cochon L; Wheeless A; Moench TR
Contraception; 2008 Feb; 77(2):130-7. PubMed ID: 18226678
[TBL] [Abstract][Full Text] [Related]
20. Macaca fascicularis vs. Macaca nemestrina as a model for topical microbicide safety studies.
Patton DL; Sweeney YC; Tsai CC; Hillier SL
J Med Primatol; 2004 Apr; 33(2):105-8. PubMed ID: 15061723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
